The SARS-CoV-2-pandemic has had a worldwide impact on every human being. The health system in Germany had to adapt in the shortest possible time. Reproductive medicine was greatly affected already early during the pandemia: many university based IVF-units were closed by order of the health ministries to gather human resources for treating potential patients infected by COVID-19. Many private centers reduced the number of patients or stopped treating patients altogether due to the fact that information on the potentially harmful effects of COVID-19 on pregnancy or gametes was sparce. The German IVF-registry (D·I·R) has performed a special analysis on the situation of ART in 2020. 113 German IVF-centers have responded by exporting their data. This paper shows the most important results, the complete results can be requested at the D·I·R-Geschäftsstelle. J Reproduktionsmed Endokrinol 2021;18 (1): 40–4. © 2021, Krause und Pachernegg GmbH. All rights reserved.
Reproductive medicine during sars-cov-2-pandemic